Research Topics
| M E MolitchSummaryAffiliation: Northwestern University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Pharmacologic resistance in prolactinoma patientsMark E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 303 E Chicago Avenue, Tarry 15 731, Chicago, IL 60611, USA
Pituitary 8:43-52. 2005..Reduction of endogenous estrogen, use of selective estrogen receptor modulators, and aromatase inhibitors are potential experimental approaches...
Prolactin excess: treatment and toxicityMary P Gillam
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA, and Endocrinology Unit, Alvarez Hospital, Buenos Aires, Argentina
Pediatr Endocrinol Rev 2:108-14. 2004..When fertility is desired, bromocriptine is generally preferable, but cabergoline is also likely safe; pergolide and quinagolide should not be used in this setting...
Growth hormone treatment in adults with growth hormone deficiency: the transitionM E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine Chicago, 645 N Michigan Avenue, Suite 530 Chicago, IL 60611, USA
J Endocrinol Invest 34:150-4. 2011..It is important for pediatric endocrinologists to discuss the potential need for continued treatment beyond achievement of adult height at the time of initiation of GH treatment, especially in those children with organic causes of GHD...
Prolactinoma in pregnancyMark E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Best Pract Res Clin Endocrinol Metab 25:885-96. 2011....
The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndromeAnne Klibanski
Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA
Pituitary 13:266-86. 2010..Panel opinions, based on the level of available scientific evidence, were polled. Finally, their views were compared with those of surveyed community-based endocrinologists and neurosurgeons...
The pituitary mass: diagnosis and managementSusan Sam
Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine
Rev Endocr Metab Disord 6:55-62. 2005
Medication-induced hyperprolactinemiaMark E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Mayo Clin Proc 80:1050-7. 2005....
Pituitary disorders during pregnancyMark E Molitch
Division of Endocrinology, Metabolism, and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Tarry 15-731, Chicago, IL 60611, USA
Endocrinol Metab Clin North Am 35:99-116, vi. 2006
Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetesMark E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, 303 E Chicago Ave Tarry 15 731, Chicago, Illinois 60611, USA
Diabetes Care 29:78-82. 2006..The objective of this study was to determine whether high levels of HDL cholesterol are associated with a lower prevalence of albuminuria..
Pituitary tumours: pituitary incidentalomasMark E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 N Michigan Avenue, Suite 530, Chicago, IL 60611, USA
Best Pract Res Clin Endocrinol Metab 23:667-75. 2009..In the absence of hypersecretion, hypopituitarism or visual field defects, patients may be followed up by periodic screening by MRI for enlargement. Growth of a pituitary incidentaloma is an indication for surgery...
Prolactin-secreting tumors: what's new?Mark E Molitch
Northwestern University Feinberg School of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, 303 E Chicago Avenue, Chicago, IL, USA
Expert Rev Anticancer Ther 6:S29-35. 2006..However, for other indications, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective or not tolerated...
Management of dyslipidemias in patients with diabetes and chronic kidney diseaseMark E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, 303 E Chicago Avenue Tarry 15 731, Chicago, IL 60611, USA
Clin J Am Soc Nephrol 1:1090-9. 2006..Overall, on the basis of the very high risk for CVD in patients with diabetes and CKD, aggressive management of dyslipidemias is warranted, with an LDL goal of 70 mg/dl...
Drugs and prolactinMark E Molitch
Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Pituitary 11:209-18. 2008..If the hyperprolactinemia is symptomatic, management strategies include switching to an alternative medication which does not cause hyperprolactinemia, using estrogen/testosterone replacement, or cautiously adding a dopamine agonist...
Nonfunctioning pituitary tumors and pituitary incidentalomasMark E Molitch
Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, 645 North Michigan Avenue, Suite 530, Chicago, IL 60611, USA
Endocrinol Metab Clin North Am 37:151-71, xi. 2008..The regrowth rate may be substantially reduced with the use of dopamine agonists and radiotherapy...
Lanreotide Autogel in the management of acromegalyMark E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Drugs 68:724. 2008
Dopamine resistance of prolactinomasMark E Molitch
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Pituitary 6:19-27. 2003..Reduction of endogenous estrogen, use of selective estrogen receptor modulators, and aromatase inhibitors are potential experimental approaches...
Disorders of prolactin secretionM E Molitch
Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois, USA
Endocrinol Metab Clin North Am 30:585-610. 2001..For other indications, cabergoline seems to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective...
Pituitary tumors and pregnancyMark E Molitch
Center for Endocrinology, Metabolism and Molecular Medicine, The Feinberg Medical School, Northwestern University, Chicago, IL, USA
Growth Horm IGF Res 13:S38-44. 2003..An increase in the size of other types of tumors during pregnancy is very rare...
Lymphocytic hypophysitisMark E Molitch
Division of Endocrinology, Metabolism, and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill 60611, USA
Horm Res 68:145-50. 2007..Lymphocytic hypophysitis is a disorder of the pituitary gland that presents as a sellar mass lesion and/or hypopituitarism. It causes pituicyte destruction and hypopituitarism and is speculated to have an autoimmune basis...
Medical management of prolactin-secreting pituitary adenomasMark E Molitch
Center for Endocrinology, Metabolism and Molecular Medicine, North Western University, The Feinberg Medical School, Chicago, IL 60611, USA
Pituitary 5:55-65. 2002..However, for other indications, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective...
Medical treatment of prolactinomasM E Molitch
Center for Endocrinology, Metabolism and Molecular Medicine, Northwestern University Medical School, Chicago, Illinois, USA
Endocrinol Metab Clin North Am 28:143-69, vii. 1999..For other indications, however, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective...
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinomaMary P Gillam
Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University, The Feinberg Medical School, Chicago, Illinois 60611, USA
J Clin Endocrinol Metab 87:4447-51. 2002..Ultimately, further reduction in PRL on this therapy permitted endogenous testosterone production. Thus, novel pharmacological maneuvers may permit successful medical treatment of some patients with invasive macroprolactinomas...
Timing and special concerns regarding endocrine surgery during pregnancySusan Sam
Division of Endocrinology, Metabolism, and Molecular Medicine, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611, USA
Endocrinol Metab Clin North Am 32:337-54. 2003..The best outcome is achieved by a multidisciplinary approach consisting of endocrinology, obstetrics, anesthesiology, and endocrine surgery...
Prolactin and autoimmune diseases in humansEllie Chuang
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
Acta Biomed 78:255-61. 2007....
Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications studyMark E Molitch
Northwestern University, Chicago, Illinois, USA
Diabetes Care 33:1536-43. 2010..73 m(2) in type 1 diabetes up to year 14 of the Epidemiology of Diabetes Interventions and Complications (EDIC) study (mean duration of 19 years in the Diabetes Control and Complications Trial [DCCT]/EDIC)...
Advances in the treatment of prolactinomasMary P Gillam
Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
Endocr Rev 27:485-534. 2006....
Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegalyRoberto Salvatori
Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Pituitary 13:115-22. 2010..0001). Self- or partner-administration of lanreotide is generally well tolerated and associated with IGF-1 and GH control in many lanreotide-naïve patients with acromegaly...
Screening for kidney disease in adults with diabetesHolly Kramer
Department of Preventive Medicine, Division of Nephrology, Loyola University Medical Center, Maywood, IL, USA
Diabetes Care 28:1813-6. 2005
Diabetes, cardiovascular risk and nephropathyAllison J Hahr
Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
Cardiol Clin 28:467-75. 2010..Reduction of other risk factors, such as smoking cessation and weight reduction, should also be implemented. Multiple risk factor reduction can have a large effect on reduction of CVD outcomes...
Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient settingAllison J Hahr
Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
Am J Ther 15:543-50. 2008..The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain...
Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient settingAllison J Hahr
Division of Endocrinology Metabolism and Molecular Medicine, Northwestern University Feinberg, School of Medicine, Chicago, Illinois
Dis Mon 56:148-62. 2010..The insulin regimen needs to be tailored to each individual, not only to maximize compliance and glycemic control but also to minimize hypoglycemia and weight gain...
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice GuidelineMark E Molitch
Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
J Clin Endocrinol Metab 91:1621-34. 2006..GH dosing regimens should be individualized. The final decision to treat adults with GHD requires thoughtful clinical judgment with a careful evaluation of the benefits and risks specific to the individual...
The relationship between glucose control and the development and progression of diabetic nephropathyCarrie A Phillips
Division of Endocrinology, Metabolism and Molecular Medicine, Feinberg School of Medicine of Northwestern University, 303 E. Chicago Avenue (Tarry 15-731, Chicago, IL 60611, USA
Curr Diab Rep 2:523-9. 2002....
Men with acquired hypogonadotropic hypogonadism treated with testosterone may be fertileAndjela Drincic
Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University, The Feinberg Medical School, Chicago, Illinois 60611, USA
Pituitary 6:5-10. 2003..This may be related to fact that gonadotropin levels in such patients are present, albeit low. Semen analyses in such men should be routinely carried out so that they can be appropriately counseled regarding potential fertility...
Posttransplant hyperglycemia is associated with increased risk of liver allograft rejectionAmisha Wallia
Division of Endocrinology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Transplantation 89:222-6. 2010..Intensive glycemic control has been shown to positively impact outcomes in an intensive care setting. Whether this practice is beneficial after liver transplantation (LT) is not known...
The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention ProgramMercedes R Carnethon
Department of Preventive Medicine, Northwestern University, Chicago, Illinois, USA
Diabetes Care 29:914-9. 2006..2 years...
Inpatient management of hyperglycemia: the Northwestern experienceAnthony J DeSantis
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
Endocr Pract 12:491-505. 2006..To describe a novel method of safe and effective intensive management of inpatient hyperglycemia with use of cost-effective protocols directed by a glucose management service (GMS)...
Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention programAllan F Moore
Center for Human Genetic Research, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA
Diabetes 57:2503-10. 2008....
Insulin resistance following cardiothoracic surgery in patients with and without a preoperative diagnosis of type 2 diabetes during treatment with intravenous insulin therapy for postoperative hyperglycemiaPatricia Liao
Division of Endocrinology, Metabolism and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
J Diabetes Complications 22:229-34. 2008..To assess insulin resistance postoperatively in patients with (DM) and without (nonDM) a prior diagnosis of diabetes...
The diabetes prevention program and its global implicationsMark E Molitch
Center for Endocrinology, Northwestern University, The Feinberg School of Medicine, Northwestern, Chicago, Illinois, USA
J Am Soc Nephrol 14:S103-7. 2003....
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomasFelipe F Casanueva
Department of Medicine, Endocrine Division, Santiago de Compostela University, Spain
Clin Endocrinol (Oxf) 65:265-73. 2006....
Inappropriate prescription for metforminMark E Molitch
JAMA 288:694; author reply 694-5. 2002
Diabetic nephropathyMark E Molitch
Diabetes Care 26:S94-8. 2003
Nephropathy in diabetesMark E Molitch
Diabetes Care 27:S79-83. 2004
Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney diseaseDennis L Andress
University of Washington School of Medicine, Seattle, Washington, USA
Endocr Pract 14:18-27. 2008..To review approved treatment options for secondary hyperparathyroidism (SHPT) in patients with stages 3 and 4 chronic kidney disease (CKD)...
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitusIan H De Boer
Division of Nephrology, University of Washington, Box 356521, 1959 NE Pacific St, Seattle, WA 98117, USA
Arch Intern Med 168:1867-73. 2008..Diabetes mellitus and hypertension are closely linked, but the long-term blood pressure effects of glucose-lowering therapy and hyperglycemia are not clear...
Research Grants
- Post-DPP Follow-Up StudyMark Molitch; Fiscal Year: 2007..women, and in older subjects in the DPP. The current application is for 5 years of funding, although the some of the goals of the projects described will require a 10-year study. ..
